Joshua Mason, US Medical Head of Tumor Agnostic (Enhertu) and Breast Cancer (Datroway) at AstraZeneca, shared a post on LinkedIn:
“I’m grateful and excited to announce my new role as US Medical Head, Tumor Agnostic (Enhertu) and Breast Cancer (Datroway) at AstraZeneca! Our journey continues towards our bold ambition, and I am looking forward to all we accomplish together. Thank you to all my mentors and team for continuing to allow me to learn from you daily and for your support in all we do.”